Suppr超能文献

生成用于监测造血分化的 CD34 荧光报告人诱导多能干细胞。

Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.

机构信息

1 Children's Cancer Research Institute (CCRI) , St. Anna Kinderkrebsforschung, Vienna, Austria .

2 Evercyte GmbH , Vienna, Austria .

出版信息

Stem Cells Dev. 2018 Oct 1;27(19):1376-1384. doi: 10.1089/scd.2018.0093. Epub 2018 Aug 21.

Abstract

Hematopoietic stem and progenitor cells (HSPCs) derived from human induced pluripotent stem cells (hiPSCs) hold great promise for disease modeling, drug screens, and eventually cell therapy approaches. During in vitro differentiation of hiPSCs into hematoendothelial progenitors, the emergence of CD34-positive cells indicates a critical step of lineage specification. To facilitate the monitoring of hematopoietic differentiation of hiPSCs, we established fluorescent reporter cells for the stem and progenitor cell marker CD34. An IRES-GFP (internal ribosome entry site green fluorescent protein) construct was introduced by CRISPR/Cas9 into the 3' untranslated region of one endogenous CD34 allele. Single-cell clones were generated after excision of the floxed puromycin resistance cassette by Cre recombination and correct insertion was confirmed by genotyping polymerase chain reaction and Southern blot. To validate their functionality, the reporter hiPSCs were in vitro differentiated toward CD34 cells using the STEMdiff Hematopoietic Kit combined with short-term inhibition of GSK3 (glycogen synthase kinase 3). All cells expressing nuclear GFP were positive for cell surface CD34, thus allowing the direct monitoring of the differentiation of hiPSCs into CD34 cells either by flow cytometry or confocal microscopy. After fluorescence-activated cell sorting, cells displaying high GFP expression exhibited increased colony-forming potential in the MethoCult colony-forming unit assays as compared with CD34 cells obtained by magnetic-activated cell sorting. In summary, we have generated functional CD34 GFP reporter hiPSCs, which not only permit label-free separation of HSPCs, but also tracing of the emergence and fate of CD34 progenitors at the single-cell level.

摘要

由人诱导多能干细胞(hiPSCs)衍生的造血干/祖细胞(HSPCs)在疾病建模、药物筛选以及最终的细胞治疗方法中具有广阔的应用前景。在 hiPSC 体外向造血内皮祖细胞分化的过程中,CD34 阳性细胞的出现标志着谱系特化的关键步骤。为了促进 hiPSC 造血分化的监测,我们建立了用于干细胞和祖细胞标志物 CD34 的荧光报告细胞。通过 CRISPR/Cas9 将 IRES-GFP(内部核糖体进入位点绿色荧光蛋白)构建体引入一个内源性 CD34 等位基因的 3'非翻译区。通过 Cre 重组切除 floxed 嘌呤霉素抗性盒后,生成单细胞克隆,并通过聚合酶链反应和 Southern blot 进行基因分型来确认正确插入。为了验证其功能,将报告 hiPSC 使用 STEMdiff 造血试剂盒与 GSK3(糖原合酶激酶 3)的短期抑制体外分化为 CD34 细胞。所有表达核 GFP 的细胞均为细胞表面 CD34 阳性,因此可以通过流式细胞术或共聚焦显微镜直接监测 hiPSC 向 CD34 细胞的分化。通过荧光激活细胞分选,与通过磁激活细胞分选获得的 CD34 细胞相比,显示高 GFP 表达的细胞在 MethoCult 集落形成单位测定中表现出更高的集落形成潜力。总之,我们已经生成了功能性 CD34 GFP 报告 hiPSC,它们不仅允许无标记分离 HSPCs,还可以在单细胞水平上追踪 CD34 祖细胞的出现和命运。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验